Avinger (NASDAQ:AVGR – Get Free Report) is anticipated to release its earnings data before the market opens on Wednesday, March 19th. Analysts expect Avinger to post earnings of ($0.40) per share and revenue of $1.86 million for the quarter.
Avinger Stock Performance
NASDAQ:AVGR opened at $0.47 on Wednesday. The company has a market capitalization of $1.57 million, a P/E ratio of -0.04 and a beta of 1.09. The stock’s 50 day moving average price is $0.56 and its 200 day moving average price is $0.79. Avinger has a 52 week low of $0.36 and a 52 week high of $4.37.
Analysts Set New Price Targets
Separately, StockNews.com began coverage on shares of Avinger in a report on Monday. They set a “hold” rating on the stock.
Avinger Company Profile
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
Featured Articles
- Five stocks we like better than Avinger
- How to Calculate Stock Profit
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- What Makes a Stock a Good Dividend Stock?
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- How to Short a Stock in 5 Easy Steps
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.
